HEADER HYDROLASE/HYDROLASE INHIBITOR 29-JAN-15 4XX4 TITLE RENIN IN COMPLEX WITH (4S)-4-ISOPROPYL-4-METHYL-6-OXO-1-(3-(2-OXO-4- TITLE 2 PHENYLPYRROLIDIN-1-YL)BENZYL)TETRAHYDROPYRIMIDIN-2(1H)-IMINIUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: LTLG NTTSSVILTN YMDTQYYGEI GIGTPPQTFK VVFDTGSSNV COMPND 8 WVPSSKCSRL YTACVYHKLF DASDSSSYKH NGTELTLRYS TGTVSGFLSQ DIITVGGITV COMPND 9 TQMFGEVTEM PALPFMLAEF DGVVGMGFIE QAIGRVTPIF DNIISQGVLK EDVFSFYYNR COMPND 10 DSENSQSLGG QIVLGGSDPQ HYEGNFHYIN LIKTGVWQIQ MKGVSVGSST LLCEDGCLAL COMPND 11 VDTGASYISG STSSIEKLME ALGAKKRLFD YVVKCNEGPT LPDISFHLGG KEYTLTSADY COMPND 12 VFQESYSSKK LCTLAIHAMD IPPPTGPTWA LGATFIRKFY TEFDRRNNRI GFALAR SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: 293 HEK KEYWDS ANIMALS, ANTIHYPERTENSIVE AGENTS, BLOOD PRESSURE, DRUG DESIGN, ENZYME KEYWDS 2 INHIBITORS, MODELS, MOLECULAR, PROTEIN CONFORMATION, RENIN, KEYWDS 3 STRUCTURE-ACTIVITY RELATIONSHIP, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 4 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.ORTH REVDAT 6 27-SEP-23 4XX4 1 HETSYN REVDAT 5 29-JUL-20 4XX4 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 18-APR-18 4XX4 1 JRNL REVDAT 3 22-NOV-17 4XX4 1 REMARK REVDAT 2 16-MAR-16 4XX4 1 REMARK REVDAT 1 18-FEB-15 4XX4 0 JRNL AUTH B.A.MCKITTRICK,J.P.CALDWELL,T.BARA,G.BOYKOW,M.CHINTALA, JRNL AUTH 2 J.CLADER,M.CZARNIECKI,B.COURNEYA,R.DUFFY,L.FLEMING, JRNL AUTH 3 R.GIESSERT,W.J.GREENLEE,C.HEAP,L.HONG,Y.HUANG,U.ISERLOH, JRNL AUTH 4 H.JOSIEN,T.KHAN,W.KORFMACHER,X.LIANG,R.MAZZOLA,S.MITRA, JRNL AUTH 5 K.MOORE,P.ORTH,M.RAJAGOPALAN,S.ROY,S.SAKWA,C.STRICKLAND, JRNL AUTH 6 H.VACCARO,J.VOIGT,H.WANG,J.WONG,R.ZHANG,A.ZYCH JRNL TITL IMINOPYRIMIDINONES: A NOVEL PHARMACOPHORE FOR THE JRNL TITL 2 DEVELOPMENT OF ORALLY ACTIVE RENIN INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 25 1592 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 25728416 JRNL DOI 10.1016/J.BMCL.2015.02.003 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 35898 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.840 REMARK 3 FREE R VALUE TEST SET COUNT : 1379 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 18 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.47 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.11 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2776 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2589 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2664 REMARK 3 BIN R VALUE (WORKING SET) : 0.2589 REMARK 3 BIN FREE R VALUE : 0.2583 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.03 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 112 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5120 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 207 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.350 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5336 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7275 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1725 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 108 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 807 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5336 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 718 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5919 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.71 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.04 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XX4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000206450. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36079 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.42800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2I4Q REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG3350, 625 MM NACL AND CITRATE REMARK 280 BUFFER PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 71.20500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.20500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 71.20500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.20500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 71.20500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 71.20500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 71.20500 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 71.20500 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 71.20500 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 71.20500 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 71.20500 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 71.20500 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 71.20500 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 71.20500 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 71.20500 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 71.20500 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 71.20500 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 71.20500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 73070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT3 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT3 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT3 3 1.000000 0.000000 0.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 618 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 67 REMARK 465 GLU B 233 REMARK 465 ASN B 234 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 GLN A 236 CG CD OE1 NE2 REMARK 470 GLN A 250 CG CD OE1 NE2 REMARK 470 LYS A 315 CG CD CE NZ REMARK 470 LYS A 341 CG CD CE NZ REMARK 470 LYS A 359 CG CD CE NZ REMARK 470 LYS A 360 CG CD CE NZ REMARK 470 ARG A 396 CD NE CZ NH1 NH2 REMARK 470 ARG B 119 CG CD NE CZ NH1 NH2 REMARK 470 TYR B 126 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 139 CG CD CE NZ REMARK 470 GLU B 144 CG CD OE1 OE2 REMARK 470 ARG B 148 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 179 CG CD OE1 OE2 REMARK 470 ARG B 205 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 220 CG CD CE NZ REMARK 470 LYS B 272 CG CD CE NZ REMARK 470 LEU B 281 CG CD1 CD2 REMARK 470 GLU B 284 CG CD OE1 OE2 REMARK 470 LYS B 315 CG CD CE NZ REMARK 470 LYS B 341 CG CD CE NZ REMARK 470 GLU B 354 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 71 24.66 -141.78 REMARK 500 ARG A 119 0.36 -69.18 REMARK 500 ASN A 141 -65.58 -132.40 REMARK 500 SER A 278 -61.34 -109.95 REMARK 500 ARG A 317 -169.97 -120.32 REMARK 500 ALA A 365 36.02 -88.85 REMARK 500 ASN B 141 -64.24 -132.99 REMARK 500 GLN B 236 30.86 -96.92 REMARK 500 THR B 280 -80.93 -72.54 REMARK 500 LEU B 281 -30.34 78.06 REMARK 500 ARG B 317 -98.15 -68.83 REMARK 500 LEU B 318 -51.06 -123.94 REMARK 500 ALA B 365 30.20 -82.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4XX3 RELATED DB: PDB DBREF 4XX4 A 67 406 UNP P00797 RENI_HUMAN 67 406 DBREF 4XX4 B 67 406 UNP P00797 RENI_HUMAN 67 406 SEQRES 1 A 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 A 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 A 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 A 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 A 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 A 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 A 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 A 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 A 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 A 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 A 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 A 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 A 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 A 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 A 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 A 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 A 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 A 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 A 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 A 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 A 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 A 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 A 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 A 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 A 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 A 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 A 340 ALA ARG SEQRES 1 B 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 B 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 B 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 B 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 B 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 B 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 B 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 B 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 B 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 B 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 B 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 B 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 B 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 B 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 B 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 B 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 B 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 B 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 B 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 B 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 B 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 B 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 B 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 B 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 B 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 B 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 B 340 ALA ARG HET NAG A 501 14 HET 70Y A 502 31 HET 70Y B 501 31 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 70Y (2Z,6S)-2-IMINO-6-METHYL-3-{3-[(4R)-2-OXO-4- HETNAM 2 70Y PHENYLPYRROLIDIN-1-YL]BENZYL}-6-(PROPAN-2-YL) HETNAM 3 70Y TETRAHYDROPYRIMIDIN-4(1H)-ONE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG C8 H15 N O6 FORMUL 4 70Y 2(C25 H30 N4 O2) FORMUL 6 HOH *207(H2 O) HELIX 1 AA1 TYR A 121 TYR A 126 1 6 HELIX 2 AA2 ASP A 131 SER A 135 5 5 HELIX 3 AA3 PRO A 181 MET A 186 1 6 HELIX 4 AA4 PHE A 198 VAL A 206 5 9 HELIX 5 AA5 PRO A 208 GLN A 216 1 9 HELIX 6 AA6 ASP A 248 GLN A 250 5 3 HELIX 7 AA7 SER A 301 GLY A 313 1 13 HELIX 8 AA8 ASN A 326 LEU A 331 5 6 HELIX 9 AA9 THR A 346 VAL A 351 1 6 HELIX 10 AB1 GLY A 382 LYS A 388 1 7 HELIX 11 AB2 TYR B 121 TYR B 126 1 6 HELIX 12 AB3 ASP B 131 SER B 135 5 5 HELIX 13 AB4 PRO B 181 MET B 186 1 6 HELIX 14 AB5 PHE B 198 VAL B 206 5 9 HELIX 15 AB6 PRO B 208 GLN B 216 1 9 HELIX 16 AB7 ASP B 248 GLN B 250 5 3 HELIX 17 AB8 SER B 301 GLY B 313 1 13 HELIX 18 AB9 ASN B 326 LEU B 331 5 6 HELIX 19 AC1 THR B 346 VAL B 351 1 6 HELIX 20 AC2 GLY B 382 LYS B 388 1 7 SHEET 1 AA1 9 LYS A 139 ARG A 148 0 SHEET 2 AA1 9 THR A 153 VAL A 165 -1 O VAL A 154 N LEU A 147 SHEET 3 AA1 9 GLN A 85 ILE A 92 -1 N GLY A 91 O THR A 164 SHEET 4 AA1 9 SER A 74 TYR A 81 -1 N TYR A 81 O GLN A 85 SHEET 5 AA1 9 GLY A 240 LEU A 244 -1 O LEU A 244 N SER A 74 SHEET 6 AA1 9 VAL A 223 TYR A 228 -1 N SER A 225 O VAL A 243 SHEET 7 AA1 9 PHE A 389 ASP A 394 -1 O PHE A 393 N PHE A 224 SHEET 8 AA1 9 ARG A 399 ALA A 405 -1 O GLY A 401 N GLU A 392 SHEET 9 AA1 9 TYR A 252 ASN A 260 -1 N ILE A 259 O ILE A 400 SHEET 1 AA213 LYS A 139 ARG A 148 0 SHEET 2 AA213 THR A 153 VAL A 165 -1 O VAL A 154 N LEU A 147 SHEET 3 AA213 ILE A 168 GLU A 179 -1 O GLU A 176 N PHE A 157 SHEET 4 AA213 VAL A 110 PRO A 113 1 N VAL A 110 O GLY A 175 SHEET 5 AA213 GLY A 192 GLY A 195 -1 O VAL A 193 N TRP A 111 SHEET 6 AA213 GLN A 97 ASP A 104 1 N VAL A 102 O VAL A 194 SHEET 7 AA213 GLN A 85 ILE A 92 -1 N GLY A 88 O VAL A 101 SHEET 8 AA213 SER A 74 TYR A 81 -1 N TYR A 81 O GLN A 85 SHEET 9 AA213 GLY A 240 LEU A 244 -1 O LEU A 244 N SER A 74 SHEET 10 AA213 VAL A 223 TYR A 228 -1 N SER A 225 O VAL A 243 SHEET 11 AA213 PHE A 389 ASP A 394 -1 O PHE A 393 N PHE A 224 SHEET 12 AA213 ARG A 399 ALA A 405 -1 O GLY A 401 N GLU A 392 SHEET 13 AA213 TYR A 252 ASN A 260 -1 N ILE A 259 O ILE A 400 SHEET 1 AA3 5 GLN A 268 MET A 271 0 SHEET 2 AA3 5 CYS A 287 VAL A 291 -1 O CYS A 287 N MET A 271 SHEET 3 AA3 5 TRP A 379 LEU A 381 1 O LEU A 381 N LEU A 290 SHEET 4 AA3 5 ILE A 298 GLY A 300 -1 N SER A 299 O ALA A 380 SHEET 5 AA3 5 ILE A 366 ALA A 368 1 O HIS A 367 N ILE A 298 SHEET 1 AA4 4 THR A 280 LEU A 282 0 SHEET 2 AA4 4 GLY A 273 VAL A 276 -1 N VAL A 274 O LEU A 282 SHEET 3 AA4 4 ILE A 334 LEU A 338 -1 O HIS A 337 N GLY A 273 SHEET 4 AA4 4 LYS A 341 LEU A 345 -1 O LEU A 345 N ILE A 334 SHEET 1 AA5 3 LYS A 315 LYS A 316 0 SHEET 2 AA5 3 TYR A 321 LYS A 324 -1 O VAL A 322 N LYS A 315 SHEET 3 AA5 3 LEU A 361 THR A 363 -1 O CYS A 362 N VAL A 323 SHEET 1 AA6 9 LYS B 139 ARG B 148 0 SHEET 2 AA6 9 THR B 153 VAL B 165 -1 O VAL B 154 N LEU B 147 SHEET 3 AA6 9 GLN B 85 ILE B 92 -1 N GLY B 91 O THR B 164 SHEET 4 AA6 9 SER B 74 TYR B 81 -1 N TYR B 81 O GLN B 85 SHEET 5 AA6 9 GLY B 240 LEU B 244 -1 O LEU B 244 N SER B 74 SHEET 6 AA6 9 VAL B 223 TYR B 228 -1 N SER B 225 O VAL B 243 SHEET 7 AA6 9 PHE B 389 ASP B 394 -1 O PHE B 393 N PHE B 224 SHEET 8 AA6 9 ARG B 399 ALA B 405 -1 O GLY B 401 N GLU B 392 SHEET 9 AA6 9 TYR B 252 ASN B 260 -1 N ILE B 259 O ILE B 400 SHEET 1 AA713 LYS B 139 ARG B 148 0 SHEET 2 AA713 THR B 153 VAL B 165 -1 O VAL B 154 N LEU B 147 SHEET 3 AA713 ILE B 168 GLU B 179 -1 O GLU B 176 N PHE B 157 SHEET 4 AA713 VAL B 110 PRO B 113 1 N VAL B 110 O GLY B 175 SHEET 5 AA713 GLY B 192 GLY B 195 -1 O VAL B 193 N TRP B 111 SHEET 6 AA713 GLN B 97 ASP B 104 1 N VAL B 102 O VAL B 194 SHEET 7 AA713 GLN B 85 ILE B 92 -1 N GLY B 88 O VAL B 101 SHEET 8 AA713 SER B 74 TYR B 81 -1 N TYR B 81 O GLN B 85 SHEET 9 AA713 GLY B 240 LEU B 244 -1 O LEU B 244 N SER B 74 SHEET 10 AA713 VAL B 223 TYR B 228 -1 N SER B 225 O VAL B 243 SHEET 11 AA713 PHE B 389 ASP B 394 -1 O PHE B 393 N PHE B 224 SHEET 12 AA713 ARG B 399 ALA B 405 -1 O GLY B 401 N GLU B 392 SHEET 13 AA713 TYR B 252 ASN B 260 -1 N ILE B 259 O ILE B 400 SHEET 1 AA8 5 GLN B 268 MET B 271 0 SHEET 2 AA8 5 CYS B 287 VAL B 291 -1 O ALA B 289 N ILE B 269 SHEET 3 AA8 5 TRP B 379 LEU B 381 1 O LEU B 381 N LEU B 290 SHEET 4 AA8 5 ILE B 298 GLY B 300 -1 N SER B 299 O ALA B 380 SHEET 5 AA8 5 ILE B 366 ALA B 368 1 O HIS B 367 N ILE B 298 SHEET 1 AA9 4 LEU B 281 LEU B 282 0 SHEET 2 AA9 4 GLY B 273 VAL B 276 -1 N VAL B 274 O LEU B 282 SHEET 3 AA9 4 ILE B 334 LEU B 338 -1 O HIS B 337 N GLY B 273 SHEET 4 AA9 4 LYS B 341 LEU B 345 -1 O LEU B 345 N ILE B 334 SHEET 1 AB1 3 LYS B 315 LYS B 316 0 SHEET 2 AB1 3 TYR B 321 LYS B 324 -1 O VAL B 322 N LYS B 315 SHEET 3 AB1 3 LEU B 361 THR B 363 -1 O CYS B 362 N VAL B 323 SSBOND 1 CYS A 117 CYS A 124 1555 1555 2.02 SSBOND 2 CYS A 283 CYS A 287 1555 1555 2.04 SSBOND 3 CYS A 325 CYS A 362 1555 1555 2.03 SSBOND 4 CYS B 117 CYS B 124 1555 1555 2.02 SSBOND 5 CYS B 283 CYS B 287 1555 1555 2.03 SSBOND 6 CYS B 325 CYS B 362 1555 1555 2.04 LINK ND2 ASN A 141 C1 NAG A 501 1555 1555 1.43 CISPEP 1 THR A 94 PRO A 95 0 -3.26 CISPEP 2 LEU A 183 PRO A 184 0 11.68 CISPEP 3 PRO A 373 PRO A 374 0 3.90 CISPEP 4 GLY A 376 PRO A 377 0 -2.10 CISPEP 5 THR B 94 PRO B 95 0 -3.03 CISPEP 6 LEU B 183 PRO B 184 0 10.74 CISPEP 7 PRO B 373 PRO B 374 0 3.47 CISPEP 8 GLY B 376 PRO B 377 0 -2.54 CRYST1 142.410 142.410 142.410 90.00 90.00 90.00 P 21 3 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007022 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007022 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007022 0.00000